{"id":"W2515900781","doi":"10.1016/s2213-2600(16)30265-x","title":"Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials","year":2016,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":466,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; University of Toronto","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Periostin; Asthma; Placebo; Exacerbation; Internal medicine; Clinical endpoint; Eosinophil; Biomarker; Bronchodilator; Exhaled nitric oxide; Wheeze; Randomized controlled trial; Spirometry; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006032156,0.0004964932,0.00429379,0.0003262484,0.0001977722,0.00001298718,0.0002423753,0.0001766399,0.0001638331],"category_scores_gemma":[0.003703231,0.0001940697,0.0001741798,0.0003582244,0.000994615,0.0001309819,0.0001110805,0.0003075231,0.000003572612],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000687549,"about_ca_system_score_gemma":0.0002639117,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002533784,"about_ca_topic_score_gemma":0.00002846795,"domain_scores_codex":[0.9953165,0.0009558465,0.001821867,0.0006497276,0.000727332,0.0005286975],"domain_scores_gemma":[0.9944744,0.002834445,0.0009948813,0.001019236,0.0002875153,0.0003895064],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9419547,0.0006276476,0.01481215,0.000130201,0.0005067271,0.00003436578,0.0002389515,0.000002498282,0.004354165,0.0001099413,0.001898577,0.03533002],"study_design_scores_gemma":[0.9356102,0.005924153,0.03919707,0.001307015,0.0007804416,0.000009547016,0.00007229461,0.00001067933,0.0006300209,0.00002924358,0.01618149,0.000247895],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9827022,0.005106641,0.00007960635,0.003730268,0.000105925,0.007092336,0.00004537385,0.00006503012,0.001072632],"genre_scores_gemma":[0.9969313,0.0002699255,0.00001979586,0.001213965,0.0008582673,0.0003245292,0.00001563013,0.00005137166,0.000315224],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03508212,"threshold_uncertainty_score":0.7913934,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04440747986722277,"score_gpt":0.3317937343828151,"score_spread":0.2873862545155923,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}